Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Hohl Benjamin. Director active across 1 company, notably Enliven Therapeutics, Inc.. Aggregated, 50 reports have been published. Split: 0 buy · 10 sells. Total volume traded: €578k. History available since 22 December 2023. The latest transaction was filed on 17 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Hohl Benjamin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10,000 shares@ US$2.488.4% of flowCommon StockSEC:0001415889-25-007286:0
25 of 50 declarations
About Hohl Benjamin
Hohl Benjamin is a declarant linked to Enliven Therapeutics, Inc., where the listed role is CHIEF FINANCIAL OFFICER. The record shows 44 filings in total, and, across the recent sample of 44 filings, the transactions show 0 EUR of buys and 301247 EUR of sales between 2023-12-27 and 2026-06-22, with the modal transaction nature listed as Levée d'options.